Pilot study of treatment with pegylated interferon and ribavirin in liver transplant recipients with hepatitis C infection

被引:0
|
作者
Roche, B
Roque-Afonso, AM
Sebagh, M
Feray, C
Guettier, C
Dussaix, E
Castaing, D
Samuel, D
机构
[1] Hosp P Brousse, Ctr Hepato Biliaire, Villejuif, France
[2] Hosp P Brousse, Dept Pathol, Villejuif, France
[3] Hosp P Brousse, Dept Microbiol, Villejuif, France
关键词
D O I
10.1016/S0168-8278(03)80561-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
145
引用
收藏
页码:48 / 49
页数:2
相关论文
共 50 条
  • [1] Pilot study of treatment with pegylated interferon and ribavirin in liver transplant recipients with hepatitis C infection
    Roche, B
    Roque-Afonso, AM
    Sebagh, M
    Feray, C
    Guettier, C
    Dussaix, E
    Castaing, D
    Samuel, D
    LIVER TRANSPLANTATION, 2003, 9 (06) : C6 - C6
  • [2] Pegylated interferon therapy with/without ribavirin in liver transplant recipients with recurrent hepatitis C infection
    Levitsky, J
    Cohen, SM
    Dasgupta, KA
    Faust, TW
    Te, HS
    HEPATOLOGY, 2002, 36 (04) : 182A - 182A
  • [3] Treatment of Recurrent Hepatitis C in Liver Transplant Recipients With Extended Duration of Pegylated Interferon and Ribavirin
    Arrigo, Richard
    Samanta, Arun
    Griffith, Shanthini
    Parekh, Ravish M.
    Korogodsky, Maria
    Rao, Kiran V.
    Fisher, Adrian
    Wilson, Dorian
    Klein, Kenneth M.
    Koneru, Baburao
    GASTROENTEROLOGY, 2011, 140 (05) : S459 - S459
  • [4] Outcome of Treatment With Pegylated Interferon and Ribavirin in Heart Transplant Recipients With Chronic Hepatitis C
    Durante-Mangoni, E.
    Ragone, E.
    Pinto, D.
    Iossa, D.
    Covino, F. E.
    Maiello, C.
    Utili, R.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (01) : 299 - 303
  • [5] A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C
    Shakil, AO
    McGuire, B
    Crippin, J
    Teperman, L
    Demetris, AJ
    Conjeevaram, H
    Gish, R
    Kwo, P
    Balan, V
    Wright, TL
    Brass, C
    Rakela, J
    HEPATOLOGY, 2002, 36 (05) : 1253 - 1258
  • [6] Combination treatment with pegylated interferon A and ribavirin in potential renal transplant recipients with chronic hepatitis C infection.
    Donaldson, K
    Pall, A
    Dillon, J
    Henderson, I
    Walsh, S
    SCOTTISH MEDICAL JOURNAL, 2006, 51 (01) : 55 - 55
  • [7] Preemptive therapy with combination pegylated interferon and ribavirin in liver transplant recipients with hepatitis C virus
    Neff, GW
    O'Brien, CB
    Safdar, K
    Ruiz, P
    Bejarano, P
    Montalbano, M
    Schiff, ER
    GASTROENTEROLOGY, 2004, 126 (04) : A695 - A695
  • [8] Outcomes of liver transplant recipients with hepatitis C receiving interferon/ribavirin treatment
    Smallwood, GA
    Devine, R
    Lehneman, J
    Connor, K
    Stieber, AC
    Heffron, TG
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 500 - 500
  • [9] IMPACT OF PEGYLATED INTERFERON AND RIBAVIRIN TREATMENT ON GRAFT SURVIVAL IN LIVER TRANSPLANT PATIENTS WITH RECURRENT HEPATITIS C INFECTION
    Veldt, B. J.
    Poterucha, J. J.
    Watt, K. D. S.
    Weisner, R. H.
    Hay, J. E.
    Kremers, W. K.
    Rosen, C. B.
    Heimbach, J. K.
    Charlton, M. R.
    LIVER TRANSPLANTATION, 2008, 14 (07) : S183 - S183
  • [10] Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection
    Veldt, B. J.
    Poterucha, J. J.
    Watt, K. D. S.
    Wiesner, R. H.
    Hay, J. E.
    Kremers, W. K.
    Rosen, C. B.
    Heimbach, J. K.
    Charlton, M. R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (11) : 2426 - 2433